Please provide your email address to receive an email when new articles are posted on . DALLAS — Preoperative counseling and perioperative pain management strategies significantly reduced opioid ...
A open label phase II trial of cetuximab plus cisplatin in patients with recurrent or metastatic undifferentiated carcinoma of nasopharyngeal type: Results after three years.
A 42-year-old female with papillary thyroid cancer with a moderate risk for recurrence presented to the endocrine clinic. She was AJCC stage 1 and her ATA risk was moderate. When the patient was aged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback